QUADRANT CAPITAL GROUP LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1650717
CINCINNATI, OH
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$743,371
+$139,570 QoQ
Shares Held
9,120
-5.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#265
of 497 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. ARWR ranks #11 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,371 | 9,120 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $603,801 | 9,630 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $274,987 | 4,142 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $140,270 | 4,067 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $244,213 | 19,169 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $18,875 | 1,004 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,534 | 802 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,655 | 410 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,493 | 262 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,313 | 239 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $11,016 | 410 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,851 | 753 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $21,640 | 852 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $39,829 | 982 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,764 | 477 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,112 | 202 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $9,841 | 214 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $29,835 | 450 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $19,166 | 307 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $24,680 | 298 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $27,319 | 412 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $30,998 | 404 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,937 | 254 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,933 | 230 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,236 | 43 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||